GlassScriptPhysician profile
Leah Bagley
NPI 1962030809
$1,804.61
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $1,020 · 2023: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $508.10 | 2021-2023 | |
| Novo Nordisk INC | $135.76 | 2021-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $130.74 | 2021-2023 | Emgality, Jardiance, Mounjaro |
| Baxter Healthcare | $115.54 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $111.62 | 2022 | |
| Dexcom, INC. | $96.73 | 2022-2023 | Dexcom G6 Transmitter |
| Cvrx, INC. | $88.10 | 2022 | |
| Xeris Pharmaceuticals, INC. | $68.60 | 2022-2023 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $59.86 | 2021-2022 | |
| Pfizer INC. | $46.61 | 2021-2023 | |
| Daiichi Sankyo INC. | $40.25 | 2021-2022 | |
| Boston Scientific Corporation | $40.15 | 2023 | Wavewriter Alpha Prime 16 |
| Novartis Pharmaceuticals Corporation | $36.38 | 2022-2023 | |
| Amgen INC. | $31.87 | 2022 | |
| Exact Sciences Corporation | $30.29 | 2023 | Cologuard Collection Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $29.15 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $27.83 | 2021-2022 | |
| Abbott Laboratories | $24.09 | 2023 | Freestyle Libre 2 |
| Edwards Lifesciences Corporation | $23.50 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $19.18 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.18 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.02 | 2023 | Rexulti |
| Nestle Healthcare Nutrition INC. | $18.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.51 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.51 | 2023 | |
| Arbor Pharmaceuticals, INC. | $13.62 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.95 | 2022 | |
| Merck Sharp & Dohme LLC | $12.45 | 2022 | |
| Hikma Pharmaceuticals USA | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Bagley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.